These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6148876)

  • 1. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
    Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
    Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ; Brunton J; Sumner DJ
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
    Nitenberg A; Chemla D; Blanchet F; Guery O; Prost JF; Dutray-Dupagne C
    J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional hemodynamic effects of the beta-adrenoceptor blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
    Nievelstein HM; Tijssen CM; Smits JF; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):118-29. PubMed ID: 2876684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
    Frohlich ED; Messerli FH; Deslinski GR; Kobrin I
    Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of carvedilol and propranolol on coronary blood flow.
    Sievert H; Frey G; Schräder R; Schmidt T; van der Does R; Kaltenbach M; Kober G
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S122-4. PubMed ID: 1974502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
    Levenson J; Simon AC; Moyse D; Bouthier J; Safar ME
    Am Heart J; 1984 Oct; 108(4 Pt 2):1177-82. PubMed ID: 6148882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.
    Stanley AJ; Bouchier IA; Hayes PC
    Gut; 1998 Feb; 42(2):283-7. PubMed ID: 9536956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
    Waller DG; Mihindukulasuriya J; Warren DJ
    Br J Clin Pharmacol; 1985 Jan; 19(1):37-43. PubMed ID: 2858216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
    Burmeister WE; Reynolds RD; Lee RJ
    Eur J Pharmacol; 1981 Oct; 75(1):7-10. PubMed ID: 6119212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.
    Hollenberg NK; Adams DF; McKinstry DN; Williams GH; Borucki LJ; Sullivan JM
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):219S-225S. PubMed ID: 37877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of general and selective beta-adrenergic antagonists on insulin-induced cardiac and selected vascular responses in rats.
    Hauck CM; Dunbar JC
    Acta Diabetol; 1999 Jun; 36(1-2):53-60. PubMed ID: 10436253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
    Dupont AG; Vanderniepen P; Bossuyt AM; Jonckheer MH; Six RO
    Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.
    Pun KK; Yeung CK; Chan MK
    Br J Clin Pharmacol; 1985 Oct; 20(4):401-4. PubMed ID: 3907676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of equiblocking doses of nadolol and propranolol on left ventricular performance.
    Le Winter MM; Curtis GP; Engler RL; Shabetai R; Verba J
    Clin Pharmacol Ther; 1979 Aug; 26(2):162-6. PubMed ID: 37012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
    Almotrefi AA; Aboul-Enein HY; Premkumar LS
    Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.